Cargando…
Recent Update on PCSK9 and Platelet Activation Experimental Research Methods: In Vitro and In Vivo Studies
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a crucial factor in the development and progression of cardiovascular diseases. PCSK9 has been demonstrated to modify LDL plasma levels and increase platelet activation, which promotes atherosclerosis, a defining feature of nearly all cardiova...
Autores principales: | Puteri, Meidi Utami, Azmi, Nuriza Ulul, Ridwan, Salbiah, Iqbal, Muhammad, Fatimah, Tresni, Rini, Tri Diana Puspita, Kato, Mitsuyasu, Saputri, Fadlina Chany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409389/ https://www.ncbi.nlm.nih.gov/pubmed/36005422 http://dx.doi.org/10.3390/jcdd9080258 |
Ejemplares similares
-
PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction
por: Puteri, Meidi Utami, et al.
Publicado: (2022) -
High-Fat Diet Enhances Platelet Activation and Is Associated with Proprotein Convertase Subtilisin Kexin 9: An Animal Study
por: Saputri, Fadlina Chany, et al.
Publicado: (2023) -
Brazilin from Caesalpinia sappan L. as a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor: Pharmacophore-Based Virtual Screening, In Silico Molecular Docking, and In Vitro Studies
por: Iqbal, Muhammad, et al.
Publicado: (2023) -
Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
por: Amalia, Muttia, et al.
Publicado: (2023) -
The neuroprotective potential of turmeric rhizome and bitter melon on aspartame-induced spatial memory impairment in rats
por: Suswidiantoro, Vicko, et al.
Publicado: (2023)